SCHEMBL19207340

SCHEMBL19207340

O=C(O)c1ccc2c(c1)ONC=C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
MAPK1 P28482 1/20 0.43
ALOX5 P09917 1/20 0.37
CA12 O43570 3/20 0.37
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
CA4 P22748 3/20 0.37
CA9 Q16790 3/20 0.37
KDM4E B2RXH2 2/20 0.37
CA6 P23280 2/20 0.37
CA7 P43166 2/20 0.37
CA14 Q9ULX7 2/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
PTGS2 P35354 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TSHR P16473 2/20 0.37
TP53 P04637 1/20 0.37
SRD5A2 P31213 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3712689 0.86 ALOX5 (0.44) ALDH1A1MAPK1ALOX5CA12CA1
Water SCHEMBL9085223 0.85 ALOX5 (0.43) ALDH1A1MAPK1ALOX5CA12CA1
SCHEMBL5586033 0.85 TSHR (0.49) ALDH1A1KDM4ETSHRHSD17B10
Hydrochloric Acid SCHEMBL10700887 0.85 ALOX5 (0.43) ALDH1A1MAPK1ALOX5CA12CA1
SCHEMBL28747754 0.81 ALOX5 (0.40) ALDH1A1MAPK1ALOX5CA12CA1
Water SCHEMBL28231965 0.77 ALOX5 (0.38) ALDH1A1MAPK1ALOX5KDM4EPOLB
SCHEMBL18770551 0.76 MKNK1 (0.41) CA12CA1CA2CA9CA14
Bicarbonate SCHEMBL28655831 0.73 MEN1 (0.33) ALDH1A1ALOX5KDM4EPOLBGAA
SCHEMBL10509467 0.71 KDM4E (0.41) ALDH1A1CA12CA9KDM4EPOLB
SCHEMBL9995986 0.71 TSHR (0.45) ALDH1A1ALOX5KDM4ETSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3411080-A2 COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES Arrakis Therapeutics, Inc. (US) 2018-12-12 EP disclosed
CN-108778345-A Compounds and methods for treating RNA-mediated diseases 阿拉基斯医疗公司 2018-11-09 CN disclosed
WO-2018030550-A1 HETEROCYCLIC COMPOUNDS WITH AN ROR(GAMMA)T MODULATING ACTIVITY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-02-15 WO disclosed
WO-2017136450-A2 COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES ARRAKIS THERAPEUTICS, INC. (US) 2017-08-10 WO disclosed